Iraq vs Saudi Arabia: The number of people with susceptibility test result for rifampicin
Iraq
618
in 2021
Saudi Arabia
591
in 2021
Iraq rank
75th
Saudi Arabia rank
77th
The number of people with susceptibility test result for rifampicin over time
- Iraq
- Saudi Arabia
How they compare
Iraq currently reports 618 against 591 in Saudi Arabia, a difference of 27.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Iraq ahead.
Iraq ranks 75th and Saudi Arabia ranks 77th of 155 countries.
Across the 2 decades both report, Iraq averaged higher in 1 and Saudi Arabia in 1.
Head to head by decade
| Decade | Iraq | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,931 | 1,131 | 800 | Iraq |
| 2020s | 363 | 590.5 | 227.5 | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Iraq or Saudi Arabia?
- Iraq, at 618 against 591 in Saudi Arabia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Iraq and Saudi Arabia?
- 27, with Iraq ahead.
- How many years of comparable data are there for Iraq and Saudi Arabia?
- 5 years are reported by both, from 2017 to 2021.
- How do Iraq and Saudi Arabia rank globally for the number of people with susceptibility test result for rifampicin?
- Iraq ranks 75th and Saudi Arabia ranks 77th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.